Literature DB >> 12676788

Transient expansion of Mac1+Ly6-G+Ly6-C+ early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras: possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions.

An D Billiau1, Sabine Fevery, Omer Rutgeerts, Willy Landuyt, Mark Waer.   

Abstract

A murine model of minor histocompatibility antigen (miHCag)-mismatched bone marrow transplantation (BMT) was used to study the development of immunoregulatory cells in the posttransplantation period and their possible involvement in the dissociated graft-versus-host (GVH) and graft-versus-leukemia (GVL) reactivity of posttransplantation donor lymphocyte infusions (DLIs). DLI, applied immediately after BMT, induced GVH disease (GVHD), but when DLI was delayed for 3 weeks, GVHD was avoided while a distinct GVL response was allowed to develop. A population of Mac1+Ly6-G+Ly6-C+ immature myeloid cells, found in small numbers in normal mice, strongly expanded in spleens of chimeras, reaching a maximum level at week 3 and returning to base level by week 12. Upon isolation, these cells exhibited interferon-gamma (IFN-gamma)-dependent, nitric oxide (NO)-mediated suppressor activity toward in vitro alloresponses, suggesting that, after in vivo DLI, they are activated by IFN-gamma to produce NO and suppress GVH reactivity. Because not only alloactivated T-cell proliferation but also leukemia cell growth was found susceptible to inhibition by exogenous NO, in vivo activation of these cells after DLI may explain the occurrence of a GVL effect despite suppression of GVHD. This suggested sequence of events was supported by the finding that the ex vivo antihost proliferative response of spleen cells, recovered shortly after in vivo DLI, was characterized by strong mRNA production of the monokines interleukin-1 (IL-1), IL-6, and tumor necrosis factor-alpha (TNF-alpha) and of inducible nitric oxide synthase (iNOS). Our data suggest that transiently expanding Mac1+Ly6-G+Ly6-C+ immature myeloid cells (probably as a result of extramedullary myelopoiesis) may play a role in controlling GVH while promoting GVL reactivity of DLI after allogeneic BMT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676788     DOI: 10.1182/blood-2002-06-1833

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse.

Authors:  Nadira Durakovic; Vedran Radojcic; Mario Skarica; Karl B Bezak; Jonathan D Powell; Ephraim J Fuchs; Leo Luznik
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

Review 2.  Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation.

Authors:  Brent H Koehn; Bruce R Blazar
Journal:  J Leukoc Biol       Date:  2017-02-01       Impact factor: 4.962

3.  Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity.

Authors:  Douglas M Heithoff; Elena Y Enioutina; Diana Bareyan; Raymond A Daynes; Michael J Mahan
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

4.  Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination.

Authors:  Satoshi Noda; Shirley A Aguirre; Andrew Bitmansour; Janice M Brown; Timothy E Sparer; Jing Huang; Edward S Mocarski
Journal:  Blood       Date:  2005-07-26       Impact factor: 22.113

Review 5.  Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD).

Authors:  Bruce R Blazar; William J Murphy
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

6.  Plasticity of Ly-6C(hi) myeloid cells in T cell regulation.

Authors:  Bing Zhu; Jennifer K Kennedy; Yue Wang; Carolina Sandoval-Garcia; Li Cao; Sheng Xiao; Chuan Wu; Wassim Elyaman; Samia J Khoury
Journal:  J Immunol       Date:  2011-08-08       Impact factor: 5.422

Review 7.  Subsets, expansion and activation of myeloid-derived suppressor cells.

Authors:  Eliana Ribechini; Verena Greifenberg; Sarah Sandwick; Manfred B Lutz
Journal:  Med Microbiol Immunol       Date:  2010-04-08       Impact factor: 3.402

8.  The MEK inhibitor trametinib separates murine graft-versus-host disease from graft-versus-tumor effects.

Authors:  Hidekazu Itamura; Takero Shindo; Isao Tawara; Yasushi Kubota; Ryusho Kariya; Seiji Okada; Krishna V Komanduri; Shinya Kimura
Journal:  JCI Insight       Date:  2016-07-07

Review 9.  Gammadelta T-cells: potential regulators of the post-burn inflammatory response.

Authors:  Martin G Schwacha
Journal:  Burns       Date:  2008-10-31       Impact factor: 2.744

10.  Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice.

Authors:  Dapeng Wang; Yu Yu; Kelley Haarberg; Jianing Fu; Kane Kaosaard; Srinivas Nagaraj; Claudio Anasetti; Dmitry Gabrilovich; Xue-Zhong Yu
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-30       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.